SCHEMBL8888198

SCHEMBL8888198

CCOC(=O)Cc1cc(C(=O)OC)ccc1NC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.52
ALDH1A1 P00352 6/20 0.51
NPC1 O15118 4/20 0.45
SMN1; SMN2 Q16637 5/20 0.43
RAB9A P51151 3/20 0.43
KDM4E B2RXH2 5/20 0.43
MAPT P10636 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 2/20 0.42
STAT1 P42224 1/20 0.42
POLB P06746 1/20 0.42
HDAC1 Q13547 1/20 0.41
TSHR P16473 2/20 0.41
HPGD P15428 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8887771 0.85 KMT2A (0.48) KMT2AALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL8888165 0.83 ALDH1A1 (0.56) KMT2AALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL3530705 0.82 ALDH1A1 (0.47) ALDH1A1NPC1KDM4EMAPTHSD17B10
SCHEMBL8887242 0.80 ALDH1A1 (0.59) KMT2AALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL2329286 0.79 NPC1 (0.46) ALDH1A1NPC1KDM4EMAPTHSD17B10
SCHEMBL11623111 0.79 ALDH1A1 (0.57) KMT2AALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL5682853 0.78 KMT2A (0.61) KMT2AALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL11622464 0.78 ALDH1A1 (0.54) KMT2AALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL8886566 0.78 ALDH1A1 (0.56) KMT2AALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL28895911 0.77 SMN1; SMN2 (0.62) KMT2AALDH1A1SMN1; SMN2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602277-A Substituted benzene derivatives useful as neuraminidase inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 1997-02-11 US disclosed
WO-1996030329-A1 SUBSTITUTED BENZENE DERIVATIVES USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARMACEUTICALS, INCORPORATED (US) 1996-10-03 WO disclosed